Stereotaxis leads the global market in cutting-edge robotic technologies created to improve the management of heart rhythm disorders and conduct endovascular procedures. The company's goal is to explore, develop, and provide robotic systems, tools, and information solutions for the interventional laboratory. These advancements assist doctors in delivering unparalleled patient care with robotic accuracy and safety, broadening the availability of minimally invasive therapy, and enhancing efficiency, connectivity, and intelligence in the operating room.